Aptorum Group Ltd Class A (APM) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.79
• Market Cap: $6.42M
• EPS: $-0.31
• 52-Week High: $4.47
• 52-Week Low: $0.65

About Aptorum Group Ltd Class A

Aptorum Group Ltd Class A is a London-based biotechnology firm dedicated to the discovery, development, and commercialization of innovative therapeutic solutions, with a primary focus on combating infectious diseases and various forms of cancer. The company boasts a robust pipeline of drug candidates, underpinned by cutting-edge research and proprietary technologies, which demonstrates its commitment to addressing significant unmet medical needs. With a strategic emphasis on rapidly advancing...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Aptorum Group Ltd Class A and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does APM pay dividends?

Aptorum Group Ltd Class A (APM) does not currently pay a regular dividend.

What is APM's market cap?

Aptorum Group Ltd Class A (APM) has a market capitalization of $6.42M with a current stock price of $0.79.